Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

Journal of Patient Safety and Risk Management, published by SAGE Publications Ltd, stands as a vital resource for the exploration and discourse surrounding safety and risk in healthcare environments. Established in 2018 and continuing through 2024, this journal delivers a rich repository of knowledge aimed at improving patient safety protocols and mitigating risks within healthcare systems. With an ISSN of 2516-0435 and an E-ISSN of 2516-0443, the journal is indexed in several categories with a notable performance in Health Policy and Health (social science), rated in Q3, while also addressing Leadership and Management in Q4. Despite the absence of an open access model, the journal provides a platform for researchers, healthcare professionals, and students to stay informed about the latest developments and evidence-based practices within the dynamically evolving landscape of patient safety. Given its Scopus rankings, which include a percentile of 46th in Health (social science) and 36th in Health Policy, the journal is positioned as a credible and impactful publication for those dedicated to enhancing patient care through robust risk management strategies.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Current Issues in Pharmacy and Medical Sciences is a prominent open-access journal published by SCIENDO, dedicated to advancing knowledge and understanding in the fields of pharmacy, biochemistry, molecular biology, and medicine. With an ISSN of 2084-980X and an E-ISSN of 2300-6676, this journal provides a platform for researchers and academics to disseminate current findings and methodologies shaping the future of these disciplines. Since its inception in 2012 and having established itself as an open-access journal since 2014, Current Issues in Pharmacy and Medical Sciences has been committed to providing high-quality, peer-reviewed content that fosters innovation and scholarly collaboration, even as it currently ranks in the Q4 category across several key areas, including Pharmacology and Biochemistry. The journal's findings are particularly relevant to professionals and students aiming to stay abreast of the latest trends and issues impacting healthcare and pharmaceutical sciences. With future issues anticipated until 2024, this journal is positioned as a vital resource for anyone engaged in the pharmaceutical and medical fields and contributing to meaningful advancements.

Physical and Engineering Sciences in Medicine is an esteemed peer-reviewed journal published by SPRINGER, dedicated to advancing the interdisciplinary fields of biomedical engineering and biophysics. With an ISSN of 2662-4729 and an E-ISSN of 2662-4737, this journal has carved a niche for itself since its inception in 2020. Situated in the Netherlands, it serves as a global platform for innovative research and developments that bridge the physical sciences and engineering with medical applications. The journal boasts a commendable range of quartile categorizations, highlighting its impact in various sectors including Instrumentation (Q1), Radiology (Q2), and Biotechnology (Q2). Its Scopus rankings further emphasize its relevance and quality, placing it in the top 15% in several categories. Being an Open Access title, it promotes the dissemination of knowledge, ensuring that vital research is accessible to all, thereby fostering collaboration among researchers, professionals, and students alike. The journal's objectives include promoting cutting-edge research, enhancing biomedical technology, and addressing complex health challenges through innovative engineering solutions, establishing it as a vital resource in the scientific community.

Simulation in Healthcare - Journal of the Society for Simulation in Healthcare, published by Lippincott Williams & Wilkins, is a leading journal dedicated to the advancing field of simulation science within healthcare. With an ISSN of 1559-2332 and an E-ISSN of 1559-713X, it serves as a vital platform for researchers, practitioners, and educators to disseminate innovative findings and methodologies related to simulation-based learning and assessment in healthcare settings. The journal, which spans from 2006 to 2024, holds a notable presence in various academic quartiles: Q2 in Education and Modeling and Simulation, and Q3 in Epidemiology and Medicine (miscellaneous), showcasing its broad impact across interdisciplinary domains. With SCOPUS rankings placing it in the 74th percentile for Social Sciences and Education, and maintaining robust contributions to the advancement of medical training, this journal is indispensable for those seeking evidence-based practices and cutting-edge knowledge in simulation methodologies. Although it does not operate under an Open Access model, subscriptions provide vital access to its high-quality content, making it an essential resource for enhancing educational and clinical practices in healthcare.

Annals of King Edward Medical University Lahore Pakistan is a prominent open access medical journal published by the Research & Medical Education Centre since 2007. With an ISSN of 2079-7192 and an E-ISSN of 2079-0694, this journal serves as a vital platform for disseminating high-quality research and educational content in the field of medicine and health sciences. Located at the illustrious King Edward Medical College, Lahore, Pakistan, it aims to foster scholarly communication among researchers, professionals, and students. The journal covers a diverse range of topics, including clinical research, medical education, public health, and healthcare innovations, encouraging contributors to present groundbreaking findings and insights. By embracing an open access model, the Annals of King Edward Medical University ensures that vital knowledge is accessible to a global audience, enhancing collaborative efforts in advancing medical science. Its commitment to excellence makes it an essential resource for those engaged in medical research and education.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

Pharmaceutical Medicine is a leading journal published by SPRINGER INT PUBL AG, dedicated to the field of pharmacology and pharmaceutical sciences. With ISSN 1178-2595 and E-ISSN 1179-1993, this journal serves as an essential platform for researchers and professionals to share groundbreaking findings and advancements in medication efficacy, safety, and innovative therapeutic strategies. Recognized for its contribution to the field, Pharmaceutical Medicine holds an impressive Q2 ranking in both Pharmacology and Medical Pharmacology categories, further underscored by its competitive Scopus rankings—positioned at 100/272 (63rd percentile) in Medical Pharmacology and 156/313 (50th percentile) in Pharmacology, Toxicology, and Pharmaceutics. Although it primarily operates on a traditional subscription basis, its robust academic reputation continues to attract a diverse readership worldwide. Addressed in the United Kingdom with facilities in Switzerland, the journal publishes authoritative articles from its inception in 2000 through to 2024, making it a pivotal resource for those seeking to enhance their understanding and application of pharmacological principles in clinical practice and research.

World of Medicine and Biology is a leading academic journal dedicated to advancing the frontiers of medical and biological sciences. Published by the Scientific Society of Anatomists, Histologists & Embryologists in Ukraine, this journal provides a collaborative platform for researchers, professionals, and students to disseminate original research, critical reviews, and insightful discussions on a wide array of topics in these dynamic fields. With the ISSN 2079-8334, the journal aspires to bridge the gap between theory and practice, focusing on innovative methodologies, latest findings, and the relevance of biology to human health. Although the journal operates under a traditional access model, it ensures comprehensive reach through various indexing services and databases, solidifying its importance in the realm of scientific inquiry. As the field continues to evolve with new discoveries and technologies, the World of Medicine and Biology remains committed to fostering academic excellence and supporting the global research community in their endeavors.